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Abstract
Background: We aimed to provide empirical evidence of how spectrum effects can affect the
sensitivity of histological assessment of Helicobacter pylori infection, which may contribute to explain
the heterogeneity in prevalence estimates across populations with expectedly similar prevalence.
Methods: Cross-sectional evaluation of dyspeptic subjects undergoing upper digestive endoscopy,
including collection of biopsy specimens from the greater curvature of the antrum for assessment
of H. pylori infection by histopathological study and polymerase chain reaction (PCR), from Portugal
(n = 106) and Mozambique (n = 102) following the same standardized protocol.
Results: In the Portuguese sample the prevalence of infection was 95.3% by histological assessment
and 98.1% by PCR. In the Mozambican sample the prevalence was 63.7% and 93.1%, respectively.
Among those classified as infected by PCR, the sensitivity of histological assessment was 96.2%
among the Portuguese and 66.3% among the Mozambican. Among those testing positive by both
methods, 5.0% of the Portuguese and 20.6% of the Mozambican had mild density of colonization.
Conclusions: This study shows a lower sensitivity of histological assessment of H. pylori infection
in Mozambican dyspeptic patients compared to the Portuguese, which may be explained by
differences in the density of colonization, and may contribute to explain the heterogeneity in
prevalence estimates across African settings.
Background
The dependence of positive and negative predictive values
of diagnostic tests on the frequency of the target condition
in the population under study is widely recognized and
easy to quantify, as predictive values are seen as post-test
probabilities of disease, determined by the pre-test proba-
bility which is changed by knowledge of the results of the
test. Sensitivity and specificity, despite being stable across
the settings in which the test is used, actually also depend
on the characteristics of patients in whom those parame-
ters were assessed. There is much evidence for varying spe-
cificity, depending on alternative diagnoses and comorbid
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conditions that affect patients without the target disease
and which may affect the test. Sensitivity is conditioned
by the severity of the disease that is being diagnosed and
comorbid conditions that may lead to false negative
results [1]. However, this possibility is often not acknowl-
edged, since these situations are much less frequently
reported [2].
The external validity of the results of studies evaluating the
accuracy of a diagnostic test may be affected by variations
in case mix - spectrum effects - either as a consequence of
flawed study designs [3], or resulting from true variation
across populations. Examples of the latter, however, are
seldom described.
We provide empirical evidence of how spectrum effects
may affect the sensitivity of histological assessment of
Helicobacter pylori infection, in two different settings, Por-
tugal and Mozambique, in which high prevalences of
infection in the general population are to be expected [4].
Methods
Dyspeptic subjects from Portugal and Mozambique
underwent upper endoscopy evaluation and gastric
biopsy samples were collected following the same stand-
ardized protocol, including the collection of biopsy spec-
imens from the greater curvature of the antrum for
assessment of H. pylori infection by histopathological
study and polymerase chain reaction (PCR), as previously
described [5,6].
The ethics committees of involved institutions approved
the study, and all participants provided written informed
consent.
Portuguese sample [5]
All workers from the Viana do Castelo shipyard, north of
Portugal, were invited for a gastric pathology survey in
1998. Four hundred and sixty volunteered to the study
and completed a physician-administered questionnaire
on digestive symptoms. An upper digestive endoscopy
was performed to 107 participants reporting dyspeptic
symptoms and biopsy samples from the antrum were
available from 106 participants (median age: 44 years,
interquartile range: 39-48 years; 96.2% men; 100%
white).
Mozambican sample [6]
Among patients observed at the outpatient department of
Gastroenterology at the Maputo Central Hospital, adults
with dyspeptic symptoms and clinical criteria for upper
digestive endoscopy were consecutively invited to this
study between August 2005 and May 2006. One gastric
cancer patient was excluded and the present series
includes 102 participants for whom antrum biopsies with
adequate size were considered for histopathological study
(median age: 37 years, interquartile range: 29-46 years;
34.3% men; 93.1% black).
Collection of biopsy specimens
The protocol included the collection of four biopsy speci-
mens--one from the greater curvature of the antrum, two
from the incisura angularis, and one from the anterior wall
of the corpus, for the histopathological study. In the
Mozambican sample only 57 subjects had biopsies from
the corpus available due to a high frequency of erroneous
labelling as corpus of samples collected from antrum or
incisura.
In the Portuguese participants an additional antral biopsy
specimen was collected for PCR analysis and for the
Mozambican subjects an antral biopsy used for his-
topathological study was also was used for PCR.
Histopathological study
Biopsy specimens were fixed in 10% formalin and embed-
ded in paraffin and cut into 4-μm sections. Modified
Giemsa stained sections were used to identify H. pylori.
Histological evaluation of samples from both settings was
performed according to the Modified Sydney system [7]
by two experienced pathologists, using a semi-quantita-
tive scoring (0 = absent; 1 = mild; 2 = moderate; 3 =
marked) for density of colonization with H. pylori.
Assessment of H. pylori infection by PCR
In Portuguese patients, total DNA was extracted from fro-
zen antral biopsy specimens using the method described
by Boom et al [8]. Briefly, biopsies were homogenized in
guanidinium isothiocyanate, using a sterile micropestle.
DNA was captured onto silica particles, washed, and
eluted in 100 ml of 10 mmol/L Tris-HCl, pH 8.3. Two
microliters were used for each PCR. H. pylori detection was
performed by multiplex amplification of vacA and cagA
genes followed by reverse hybridization on a line probe
assay (LiPA) as described earlier [9].
In Mozambican samples, DNA was extracted from forma-
lin-fixed, paraffin-embedded antral biopsy specimens
after digestion with Proteinase K for at least 12 hours at
55°C. Proteinase K was inactivated by incubation at 95°C
for 10 minutes. Ten microliters of the lysate were used for
PCR. Detection of H. pylori was performed with the same
primers used for the Portuguese samples. Amplified prod-
ucts were visualised after electrophoresis in 2% agarose
gels.
Data analysis
Since only one biopsy (from the antrum) was used for
PCR, we compared the results of PCR assessment of infec-
tion with those from histological assessment using aBMC Gastroenterology 2009, 9:98 http://www.biomedcentral.com/1471-230X/9/98
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biopsy collected from a similar location, to ensure the
comparability of the two results obtained with the two
methods. PCR was defined as the reference standard and
sensitivity of histological assessment was computed with
respective 95% Confidence Intervals (95%CI). Propor-
tions were compared using the χ 2 test.
Sensitivity analyses were also conducted comparing the
results from the histological assessment of infection in
four biopsies collected from different stomach locations
with those from PCR evaluation of the antral specimen,
and restricting the analysis to subjects not reporting previ-
ous eradication and/or proton pump inhibitors (PPI)/H2
receptor blockers treatment.
Results
In the Portuguese sample the prevalence of infection was
95.3% by histological assessment and 98.1% by PCR. In
the Mozambican sample the prevalence was 63.7% and
93.1%, respectively.
Among those classified as infected by PCR, 96.2% of the
Portuguese and 66.3% of the Mozambican participants
yielded a positive result by histological assessment. The
sensitivity estimates were similar when only the subjects
reporting no previous eradication and/or PPI/H2 receptor
blockers treatment were considered (Table 1). Among
those testing positive by both methods, 5.0% of the Por-
tuguese and 20.6% of the Mozambican had mild density
of colonization (χ 2 test, 2 degrees of freedom: p = 0.008).
Among the Mozambicans, sensitivity was not improved
when defining infection by histopathological analysis of 4
biopsy samples from corpus, antrum and incisura angularis
(66.7%, 95%CI: 52.9%-78.5%).
Thirty percent of the Mozambican subjects reported a pre-
vious eradication treatment, with a similar prevalence of
infection and H. pylori density score regardless of treat-
ment (previous eradication therapy vs. no previous treat-
ment: no infection - 34.5% vs. 33.9%; mild - 17.2% vs.
12.9%; moderate - 10.3% vs. 29.0%; marked - 37.9% vs.
24.2%, p = 0.195). Fifty-seven percent of the Mozambican
subjects reported a previous treatment with PPI/H2 recep-
tor blockers with a similar prevalence of infection and H.
pylori density score regardless of treatment (previous treat-
ment with PPI/H2 receptor blockers vs. no previous treat-
ment: no infection - 29.6% vs. 40.5%; mild - 11.1% vs.
16.2%; moderate - 22.2% vs. 24.3%; marked - 37.0% vs.
18.9%, p = 0.304). Among the Portuguese participants,
6% reported previous eradication therapy, and 25%
declared to have used PPI/H2 receptor blockers.
Discussion
The sensitivity of the histological assessment of H. pylori
infection was considerably lower in Mozambique than in
Portugal, which may be explained by a lower density of
colonization among Mozambican patients.
In Portuguese samples, DNA was extracted from frozen
antral biopsies and used for PCR, followed by reverse
Table 1: Sensitivity of histological assessment of Helicobacter pylori infection using PCR analysis as the reference standard, in 
Portuguese and Mozambican populations of dyspeptic patients.
Helicobacter pylori infection
PCR (reference standard) Histological assessment (index text)
+ + - Sensitivity (95%CI)
All participants
Portugal 104 100* 4 96.2 (90.4-98.9)
Mozambique 95 63† 32 66.3 (55.9-75.7)
Participants not reporting previous eradication treatment
Portugal 97 95‡ 2 97.9 (92.7-99.7)
Mozambique 62 41§ 21 66.1 (53.0-77.7)
Participants not reporting previous PPI/H2 receptor blockers 
treatment
Portugal 75 74# 1 98.7 (92.8-100.0)
Mozambique 37 22¶ 15 59.4 (42.1-75.2)
Excluding participants reporting previous eradication and PPI/H2 
receptor blockers treatments
Portugal 97 95** 2 97.9 (92.7-99.7)
Mozambique 66 42†† 24 63.6 (50.9-75.1)
PCR - Polymerase chain reaction; 95%CI - 95% confidence interval; PPI - Proton pump inhibitors * H. pylori density score: mild (5.0%); moderate 
(42.0%); marked (53.0%), † H. pylori density score: mild (20.6%); moderate (34.9%); marked (44.4%), ‡ H. pylori density score: mild (5.3%); moderate 
(42.1%); marked (52.6%), §H. pylori density score: mild (19.5%); moderate (43.9%); marked (36.6%), # H. pylori density score: mild (5.4%); moderate 
(44.6%); marked (50.0%), ¶H. pylori density score: mild (27.3%); moderate (40.9%); marked (31.8%), ** H. pylori density score: mild (5.3%); moderate 
(42.1%); marked (52.6%), †† H. pylori density score: mild (21.4%); moderate (42.9%); marked (35.7%)BMC Gastroenterology 2009, 9:98 http://www.biomedcentral.com/1471-230X/9/98
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hybridization onto specific probes, whereas in Mozam-
bican samples, DNA was extracted from formalin-fixed,
paraffin-embedded biopsies and used for PCR, followed
by electrophoresis in agarose gels stained with ethidium
bromide. Visual inspection of PCR products on agarose
gels provides only limited reliability, as compared to
hybridization to allele-specific probes. However, it has
been previously shown that H. pylori genotypes obtained
from paraffin sections matched those corresponding cul-
tured strains [10]. Nevertheless, even if PCR results for
Mozambican samples were underestimated, this would
mean that the sensitivity of histological assessment for
this population would even be lower, and more discrep-
ant than those obtained for the Portuguese samples.
Co-infections with other Helicobacter species have been
described in African populations [11], but the PCR analy-
sis that we have used is specific for H. pylori (we have used
primers directed to the vacA gene which is only present in
this species). Primer sequences used in this study were
analyzed for specificity by using the Blast program at the
National Institute of Health Data libraries [12].
The histological identification of H. pylori in tissue sec-
tions may be affected by biopsy and observer-related fac-
tors. Sensitivity is higher when at least samples from the
antrum and the body are analyzed, but the proportion of
infected subjects did not vary meaningfully when we con-
sidered the histological assessment of infection status
using biopsies from the three locations, which is in
accordance with the fact that the antrum biopsies tend to
yield a higher prevalence of infection than the other loca-
tions [13], strengthening the validity of our conclusions.
Moreover, no meaningful increase in the prevalence of
infection when assessed by PCR was to be expected, as it
was well above 90% when only one biopsy is used for this
purpose.
Staining methods such as modified Giemsa are highly
sensitive, but histological examination relies on the expe-
rience of the histopathologist to recognize the typical
morphology of the organism, and small numbers of
organisms may be missed [14,15], while PCR methods
have been described as more sensitive and not dependent
on the level of experience of the pathologist [16,17].
In our study, samples from both settings were collected
and processed following similar methods and were evalu-
ated by the same experienced pathologists. It is unlikely
that differences in technical aspects or inter-observer and
laboratory variations explain the differences in the results
obtained in Portuguese and Mozambican samples. The
same applies to the grading of the density of colonization,
which was conducted following the same criteria in both
samples.
Although coccoid forms (suggesting possible degenerative
forms of H. pylori) could have been found in the negative
specimens, and would contribute to the low perceived
sensitivity of histological assessment of infection, the
pathologists where aware of this possibility. Even consid-
ering the difficulties in classifying correctly these unchar-
acteristic forms in the absence of findings of structures
with the characteristic H. pylori shape, these were seldom
observed and the differences observed in sensitivity or in
the density of H. pylori colonization cannot be ascribed to
such phenomenon.
A lower sensitivity of histology for the assessment of H.
pylori infection has been recognized after partially effective
eradication therapy [15,16], as low levels of recurrent
infection can be easily missed by biopsy, leading to over-
estimation of therapeutic efficacy [18]. The proportion of
Mozambican subjects reporting a previous eradication
treatment was surprisingly high, which could explain the
lower density of colonization among these patients, but
no information was obtained regarding the success of
eradication or time since eradication. No significant dif-
ferences were found in infection status or density of H.
pylori colonization according to self-reported eradication
treatment, probably reflecting the large potential for erro-
neous reporting of such a specific therapy, and sensitivity
was similar when only subjects not reporting an eradica-
tion treatment were considered. Similarly, the previous
use of PPI/H2 receptor blockers was also self-reported and
no information was collected regarding current treatment
or time since last treatment course, but sensitivity was
similar when only subjects not reporting the use of PPI/
H2 receptor blockers were considered.
Gastric atrophy and intestinal metaplasia lead to a pH
increase in the stomach, which can create an unfavorable
environment for H. pylori survival, and could contribute
to lower density of colonization [19,20]. The density of H.
pylori  may be increased in macroscopic erosions [21].
However, only 14.7% of the Mozambican patients had
chronic atrophic gastritis (5.9%) or intestinal metaplasia
(8.8%), in comparison with 43.9% in the Portuguese sub-
jects (chronic atrophic gastritis: 6.5%; intestinal metapla-
sia: 37.4%), and erosions/ulcerations were observed in
one Portuguese and four Mozambicans. Therefore, the
unequal distribution of these lesions could not explain
the differences in the prevalence of infection detected by
histology.
Although the samples were evaluated in different time
periods and present different characteristics regarding the
participants' ethnicity and gender, our analysis only
included subjects testing positive for H. pylori infection by
PCR and the above differences between the Portuguese
and the Mozambican sample are not likely to account for
our conclusions.BMC Gastroenterology 2009, 9:98 http://www.biomedcentral.com/1471-230X/9/98
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In studies conducted in dyspeptic patients from different
African populations the overall prevalence of H. pylori
infection, assessed by histology, was approximately 72%,
varying from 25% in Uganda to 97% in Ghana [22],
although a high prevalence of infection is expected given
its strong association with low socioeconomic status. The
heterogeneity of estimates across African settings, as well
as unexpectedly low figures, is likely to be explained both
by observer-related factors and differences in the density
of colonization by H. pylori.
Mozambique and other African countries have a low fre-
quency of gastric cancer and gastric precancerous lesions,
despite the high prevalence of infection [23,24], reflecting
what has been called the African enigma. In addition to
providing an example of how spectrum effects can affect
the sensitivity of histological assessment of H. pylori infec-
tion, our results add a piece of information to our current
understanding of the "enigma", suggesting that despite
the absence of differences in the frequency of infection
with the more virulent strains in Portugal and Mozam-
bique [25], the higher prevalence of mild infections in
Africa may be associated with a lower incidence of cancer.
Conclusions
This study provides empirical evidence of how subtle
spectrum effects, not induced by a flawed study design,
may be responsible for large differences on the sensitivity
of histological assessment of H. pylori infection, and may
contribute to explain the heterogeneity in prevalence esti-
mates across African settings.
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